Open access · CC-BY
via OpenAlex
Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial
Elizabeth Mary Curtis, Rebecca Jane Moon, Stefania D’Angelo, Sarah Crozier, Nicholas J. Bishop, Jaya Sujatha Gopal‐Kothandapani, Stephen Kennedy, Aris T. Papageorghiou, Robert B. Fraser, Saurabh V. Gandhi, Inez Schoenmakers, Ann Prentice, Hazel M. Inskip, Keith M. Godfrey, M K Javaid
JBMR Plus · 2022 · ▲ 32 citations
Abstract
ABSTRACT In the Maternal Vitamin D Osteoporosis Study (MAVIDOS) randomized trial, vitamin D supplementation in pregnancy did not lead to greater neonatal bone mass across the trial as a whole, but, in a prespecified secondary analysis by season of birth, led to greater neonatal bone mass among winter‐born babies. Demonstrating persistence of this effect into childhood would increase confidence in a long‐term benefit of this intervention. We investigated whether antenatal vitamin D supplementation increases offspring bone mineralization in early childhood in a prespecified, single‐center follow‐up of a double‐blinded, multicenter, randomized controlled clinical trial based in the UK (MAVIDOS). A total of 1123 women in early pregnancy with a baseline 25‐hydroxyvitamin D level 25–100 nmol/L from three research centers (2008–2014) were randomized to 1000 IU/d cholecalciferol or matched placebo from 14 weeks of gestation to delivery. Offspring born at the Southampton, UK research center were assessed at age 4 years (2013–2018). Anthropometry and dual‐energy X‐ray absorptiometry (DXA) were performed (yielding whole body less head [WBLH] bone mineral content [BMC], areal bone mineral density [aBMD], bone area [BA], and body composition). Of 723 children, 564 (78.0%) children attended the 4‐year visit, 452 of whom had a useable DXA. Maternal vitamin D supplementation led to greater WBLH aBMD in the children compared with placebo (mean [95% confidence interval {CI}]: supplemented group: 0.477 (95% CI, 0.472–0.481) g/cm 2 ; placebo group: 0.470 (95% CI, 0.466–0.475) g/cm 2 , p = 0.048). Associations were consistent for BMC and lean mass, and in age‐ and sex‐adjusted models. Effects were observed across the whole cohort irrespective of season of birth. Maternal‐child interactions were observed, with a greater effect size among children with low milk intake and low levels of physical activity. Child weight, height, and body mass index (BMI) were similar by maternal randomization group. These findings suggest a sustained beneficial effect of maternal vitamin D supplementation in pregnancy on offspring aBMD at age 4 years, but will require replication in other trials. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/jbm4.10651
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Curtis, E.M., Moon, R.J., D’Angelo, S., Crozier, S., Bishop, N.J., Gopal‐Kothandapani, J.S., Kennedy, S., Papageorghiou, A.T., Fraser, R.B., Gandhi, S.V., Schoenmakers, I., Prentice, A., Inskip, H.M., Godfrey, K.M., Javaid, M.K., Eastell, R., Cooper, C.C., Harvey, N.C., & Group, T.M.T. (2022). Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial. <em>JBMR Plus</em>. https://doi.org/10.1002/jbm4.10651
Vancouver
Curtis EM, Moon RJ, D’Angelo S, Crozier S, Bishop NJ, Gopal‐Kothandapani JS, et al. Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial. JBMR Plus. 2022. doi:10.1002/jbm4.10651.
BibTeX
@article{elizabeth2022Pregna,
title = {Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial},
author = {Elizabeth Mary Curtis and Rebecca Jane Moon and Stefania D’Angelo and Sarah Crozier and Nicholas J. Bishop and Jaya Sujatha Gopal‐Kothandapani and Stephen Kennedy and Aris T. Papageorghiou and Robert B. Fraser and Saurabh V. Gandhi and Inez Schoenmakers and Ann Prentice and Hazel M. Inskip and Keith M. Godfrey and M K Javaid and Richard Eastell and Cyrus C. Cooper and Nicholas C. Harvey and the MAVIDOS Trial Group},
journal = {JBMR Plus},
year = {2022},
doi = {10.1002/jbm4.10651},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrition in Clinical Practice 2013
Preprint · OA
The Role of Dietary Protein Intake in the Prevention of Sarcopenia of Aging
Translational Medicine of Aging 2020
Open access · CC-BY
A nonrandomized study of single oral supplementation within the daily tolerable upper level of nicotinamide affects blood nicotinamide and NAD+ levels in healthy subjects
Consorci Sanitari del Maresme 2017
Open access · US-GOV
Efficacy of a Multimodal Intervention in the Prevention of Frailty in Obese Elderly People and Study of the Pathophysiological Mechanisms Involved
Journal of Clinical Oncology 2024
Citation only
Impact of urolithin A supplementation, a mitophagy activator on mitochondrial health of immune cells (MitoIMMUNE): A randomized, double-blind, placebo-controlled trial in healthy adults.
Nutrients 2024
Open access · CC-BY
Effect of Early Time-Restricted Eating on Metabolic Markers and Body Composition in Individuals with Overweight or Obesity
International Journal of Epidemiology 2016
Open access · CC-BY